Fredrik SjövallChairman of the board
With an MSc from Chalmers University of Technology. Fredrik is also Chairman of Ziccum AB, Board member of Lipidor AB and Axelero AB. Previously Fredrik has been the CEO of Inhalation Sciences AB (publ), PharmaSurgics and Lipopeptide (now Promore Pharma). He has nearly 15 years’ experience as CEO of start-up companies in the life science industry.
Number of shares: 205,987 (through Axelero AB) Number of warrants: no warrants.
Klaus Gottwald, a systems analyst and economics alumnus from Stockholm University, is co-founder and CEO of Stockholms Affärsänglar (STOAF/Stockholm Business Angels), one of Sweden’s most prestigious and successful early stage investment funds, financing high technology and life science ventures. He is also CEO of Sustainable Energy Angels, an early stage investment fund focused on smart grid and renewable energy solutions. From 1995-2000 he was founder and CEO of MAS Sweden AB. Mr. Gottwald has extensive strategic, board and executive experience. He has been instrumental in establishing, leading and developing companies in strong and rapid growth across a range of industries.
Number of shares: 14,581 shares (through Vendevo AB) as well as, indirectly, 3,453 shares (Stockholms affärsänglar management AB). Number of warrants: no warrants.
Associate Professor of Inhalation Toxicology. Scientist at the Division of Physiology, Institute of Environmental Medicine at the Karolinska Institutet. Previous appointments include scientist at the Lovelace Respiratory Research Institute (1993– 1998), scientist at the Swedish National Institute of Occupational Health (1991–1996), and postdoctoral fellow at the Lovelace Respiratory Research Institute (1989–1991). Dr. Gerde has published approx. 30 peer reviewed scientific papers. He is also the main inventor of six patent families with related patent applications.
Number of shares: 771 140 shares. Number of warrants: 60 000 warrants.
With an MSc in Industrial Economics from Linköping University. Sonja works as an Investment Manager at Impilo. From 2014 to 2017 she worked as a consultant at the Boston Consulting Group in Stockholm.
Number of shares: 54,750 shares. Number of warrants: no warrants.
Tom has over 20 years’ experience in the Life Science industry, including 10 in roles in the global inhalation market. His background includes roles as CEO of Quickels Systems AB and IM-Medico AB, Global Sales Director at Aerocrine and Board member of Näslund Medical AB. Tom has extensive experience of international sales and marketing, and of building global distributor networks.
Number of shares: 1,577 shares. Number of warrants: no warrants.